Twist Bioscience holder proposes $44.7M share sale
Twist Bioscience Corp (TWST) security holder Emily M. Leproust has provided notice under Rule 144 of a proposed sale of up to 295,037 shares of common stock, with an aggregate market value of $44,677,452.91, expected around September 17, 2026 on NASDAQ.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) security holder Emily M. Leproust has provided notice under Rule 144 of a proposed sale of up to 295,037 shares of common stock, with an aggregate market value of $44,677,452.91, expected around September 17, 2026 on NASDAQ.
The notice lists these shares as having been acquired through various restricted stock vestings, an ESPP purchase, and a stock option exercise for 208,708 shares. Twist Bioscience Corp reports 62,707,424 common shares outstanding as of September 17, 2026; this is a baseline figure, not the amount being sold.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
ESPP Purchase financial
Stock Option Exercise financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who is acting for Emily M. Leproust in connection with the TWST Rule 144 notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.